Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q166
SBA

SBA — Single Best Answer · Review

Question 166

Delivery suite → Haemorrhage

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 522c2a31-24ce-4d9d-9dd1-e92c4599a498

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Delivery suite
Topic
Haemorrhage
Subtopic 1
Antepartum haemorrhage
Subtopic 2
General
Subtopic 3
Rhesus prophylaxis
Question Type
SBA

Question

SSBA
Question Header
An unsensitised RhD-negative woman has recurrent APH at 29, 31 and 33 weeks. She received anti-D after the first episode. Following the third episode, a colleague argues that no further prophylactic assessment is necessary because all three bleeds probably arise from the same placental pathology. Which principle is most appropriate?
Question Stem
—

Options

A Anti-D is required only for the first APH occurring in any pregnancy
B Recurrent APH should be managed as potentially repeated sensitising exposure, with anti-D prophylaxis and assessment according to gestation, timing and fetomaternal haemorrhage
C Anti-D should be withheld once placental abruption has been clinically suspected
D Kleihauer testing can replace anti-D prophylaxis when recurrent bleeding occurs
E Anti-D is unnecessary if fetal monitoring remains reassuring

Explanation

Recurrent APH in an unsensitised RhD-negative woman creates continuing or repeated potential exposure to fetal RhD-positive cells. Previous administration of anti-D does not justify assuming that all later bleeding is already covered indefinitely. Further prophylaxis should therefore be considered according to the timing and gestation of recurrent sensitising events, with assessment of fetomaternal haemorrhage where indicated to determine whether additional anti-D is required. Neither fetal wellbeing nor the presumed placental cause determines whether maternal sensitisation can occur.

Option Validity

A) A previous dose does not necessarily provide adequate prophylaxis for all subsequent sensitising episodes.

C) Suspected placental abruption does not remove the indication for appropriate RhD prophylaxis.

D) Kleihauer testing quantifies fetomaternal haemorrhage; it does not itself provide immunoprophylaxis.

E) A reassuring fetal heart rate does not determine the risk of maternal RhD sensitisation.

Further Reading

RCOG Green-top Guideline No. 63. Antepartum Haemorrhage. Royal College of Obstetricians and Gynaecologists; 2011.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
Site
Source
—
Source Section
—
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question